This Unit is responsible for international sales, including exports to Eurofarma subsidiaries outside Brazil.
This Unit is a generator of intercultural intelligence. It works to map and expand the company’s operations into new international markets, by establishing new partnerships abroad and extending the portfolio of products commercialized out of Brazil. This area’s objective is to establish attractive, profitable, and long-term international partnerships. Our products are exported to countries in Latin America, Africa and Asia. Our production facilities have been certified by: Anvisa (Brazil), Anmat (Argentina), Invima (Colombia), ISP – Public Health Institute (Chile), the Department of Regulation and Control of Pharmaceutical and Related Products (Guatemala), Digemid (Peru), and the Ministry of Public Health of Uruguay.
At the end of 2022, the FDA (U.S. Food and Drug Administration), the agency that regulates drug use and commercialization in the United States, inspected the Unit of Itapevi. FDA has granted to Eurofarma the Voluntary Action Indicated (VAI) classification, indicating that the company complies with the required manufacturing standards and good practices to ensure the future approval of products in the American market.
We are able to provide our dossier for registration in your country, and to manufacture finished products with all related packaging in the desired language, with their own layout and brand name, or as generic drug.
Contact us: export@eurofarma.com.br
Tel .: +55 11 5090-8487
Click to download an available dossiers: PDF or XLS